Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial.

Brasky TM, Till C, White E, Neuhouser ML, Song X, Goodman P, Thompson IM, King IB, Albanes D, Kristal AR.

Am J Epidemiol. 2011 Jun 15;173(12):1429-39. doi: 10.1093/aje/kwr027. Epub 2011 Apr 24. Erratum in: Am J Epidemiol. 2013 Dec 1;178(11):1680.

2.

Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer.

Chan JM, Weinberg V, Magbanua MJ, Sosa E, Simko J, Shinohara K, Federman S, Mattie M, Hughes-Fulford M, Haqq C, Carroll PR.

Cancer Causes Control. 2011 Jan;22(1):141-50. doi: 10.1007/s10552-010-9684-5. Epub 2010 Nov 20.

3.

Fish consumption and prostate cancer risk: a review and meta-analysis.

Szymanski KM, Wheeler DC, Mucci LA.

Am J Clin Nutr. 2010 Nov;92(5):1223-33. doi: 10.3945/ajcn.2010.29530. Epub 2010 Sep 15. Review.

4.

Computer-assisted pathological immunohistochemistry scoring is more time-effective than conventional scoring, but provides no analytical advantage.

Ong CW, Kim LG, Kong HH, Low LY, Wang TT, Supriya S, Kathiresan M, Soong R, Salto-Tellez M.

Histopathology. 2010 Mar;56(4):523-9. doi: 10.1111/j.1365-2559.2010.03496.x.

PMID:
20459559
5.

Dietary fat and early-onset prostate cancer risk.

Lophatananon A, Archer J, Easton D, Pocock R, Dearnaley D, Guy M, Kote-Jarai Z, O'Brien L, Wilkinson RA, Hall AL, Sawyer E, Page E, Liu JF, Barratt S, Rahman AA; UK Genetic Prostate Cancer Study Collaborators; British Association of Urological Surgeons' Section of Oncology, Eeles R, Muir K.

Br J Nutr. 2010 May;103(9):1375-80. doi: 10.1017/S0007114509993291. Epub 2010 Jan 19.

PMID:
20082736
6.

Growth inhibitory effect of low fat diet on prostate cancer cells: results of a prospective, randomized dietary intervention trial in men with prostate cancer.

Aronson WJ, Barnard RJ, Freedland SJ, Henning S, Elashoff D, Jardack PM, Cohen P, Heber D, Kobayashi N.

J Urol. 2010 Jan;183(1):345-50. doi: 10.1016/j.juro.2009.08.104.

7.

Omega-3 fatty acids, genetic variants in COX-2 and prostate cancer.

Reese AC, Fradet V, Witte JS.

J Nutrigenet Nutrigenomics. 2009;2(3):149-58. doi: 10.1159/000235565. Epub 2009 Sep 23. Review.

8.

Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk.

Fradet V, Cheng I, Casey G, Witte JS.

Clin Cancer Res. 2009 Apr 1;15(7):2559-66. doi: 10.1158/1078-0432.CCR-08-2503. Epub 2009 Mar 24.

9.

Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study.

Berney DM, Gopalan A, Kudahetti S, Fisher G, Ambroisine L, Foster CS, Reuter V, Eastham J, Moller H, Kattan MW, Gerald W, Cooper C, Scardino P, Cuzick J.

Br J Cancer. 2009 Mar 24;100(6):888-93. doi: 10.1038/sj.bjc.6604951.

10.

Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery.

Demark-Wahnefried W, Polascik TJ, George SL, Switzer BR, Madden JF, Ruffin MT 4th, Snyder DC, Owzar K, Hars V, Albala DM, Walther PJ, Robertson CN, Moul JW, Dunn BK, Brenner D, Minasian L, Stella P, Vollmer RT.

Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3577-87. doi: 10.1158/1055-9965.EPI-08-0008.

11.

Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition.

Crowe FL, Allen NE, Appleby PN, Overvad K, Aardestrup IV, Johnsen NF, Tjønneland A, Linseisen J, Kaaks R, Boeing H, Kröger J, Trichopoulou A, Zavitsanou A, Trichopoulos D, Sacerdote C, Palli D, Tumino R, Agnoli C, Kiemeney LA, Bueno-de-Mesquita HB, Chirlaque MD, Ardanaz E, Larrañaga N, Quirós JR, Sánchez MJ, González CA, Stattin P, Hallmans G, Bingham S, Khaw KT, Rinaldi S, Slimani N, Jenab M, Riboli E, Key TJ.

Am J Clin Nutr. 2008 Nov;88(5):1353-63.

12.

A 22-y prospective study of fish intake in relation to prostate cancer incidence and mortality.

Chavarro JE, Stampfer MJ, Hall MN, Sesso HD, Ma J.

Am J Clin Nutr. 2008 Nov;88(5):1297-303.

13.

Prostaglandin E2 regulates tumor angiogenesis in prostate cancer.

Jain S, Chakraborty G, Raja R, Kale S, Kundu GC.

Cancer Res. 2008 Oct 1;68(19):7750-9. doi: 10.1158/0008-5472.CAN-07-6689.

14.

Circulating fatty acids and prostate cancer risk in a nested case-control study: the Multiethnic Cohort.

Park SY, Wilkens LR, Henning SM, Le Marchand L, Gao K, Goodman MT, Murphy SP, Henderson BE, Kolonel LN.

Cancer Causes Control. 2009 Mar;20(2):211-23. doi: 10.1007/s10552-008-9236-4. Epub 2008 Sep 27.

15.

Long-term assessment of prostate cancer progression free survival: evaluation of pathological parameters, nuclear shape and molecular biomarkers of pathogenesis.

Veltri RW, Isharwal S, Miller MC, Epstein JI, Mangold LA, Humphreys E, Partin AW.

Prostate. 2008 Dec 1;68(16):1806-15. doi: 10.1002/pros.20848.

16.

Multi-targeted therapy of cancer by omega-3 fatty acids.

Berquin IM, Edwards IJ, Chen YQ.

Cancer Lett. 2008 Oct 8;269(2):363-77. doi: 10.1016/j.canlet.2008.03.044. Epub 2008 May 13. Review.

17.

Dietary fat intake and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition.

Crowe FL, Key TJ, Appleby PN, Travis RC, Overvad K, Jakobsen MU, Johnsen NF, Tjønneland A, Linseisen J, Rohrmann S, Boeing H, Pischon T, Trichopoulou A, Lagiou P, Trichopoulos D, Sacerdote C, Palli D, Tumino R, Krogh V, Bueno-de-Mesquita HB, Kiemeney LA, Chirlaque MD, Ardanaz E, Sánchez MJ, Larrañaga N, González CA, Quirós JR, Manjer J, Wirfält E, Stattin P, Hallmans G, Khaw KT, Bingham S, Ferrari P, Slimani N, Jenab M, Riboli E.

Am J Clin Nutr. 2008 May;87(5):1405-13.

18.

Effect of low-fat diet on development of prostate cancer and Akt phosphorylation in the Hi-Myc transgenic mouse model.

Kobayashi N, Barnard RJ, Said J, Hong-Gonzalez J, Corman DM, Ku M, Doan NB, Gui D, Elashoff D, Cohen P, Aronson WJ.

Cancer Res. 2008 Apr 15;68(8):3066-73. doi: 10.1158/0008-5472.CAN-07-5616.

19.

Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids.

Berquin IM, Min Y, Wu R, Wu J, Perry D, Cline JM, Thomas MJ, Thornburg T, Kulik G, Smith A, Edwards IJ, D'Agostino R, Zhang H, Wu H, Kang JX, Chen YQ.

J Clin Invest. 2007 Jul;117(7):1866-75.

20.

The effects of a high-fruit and -vegetable, high-fiber, low-fat dietary intervention on serum concentrations of insulin, glucose, IGF-I and IGFBP-3.

Flood A, Mai V, Pfeiffer R, Kahle L, Remaley AT, Rosen CJ, Lanza E, Schatzkin A.

Eur J Clin Nutr. 2008 Feb;62(2):186-96. Epub 2007 May 9.

PMID:
17487212

Supplemental Content

Support Center